Vol. 47 No. 1 (2008): Acta Oncologica

Articles

• Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab

  Fernando Rivera, Ma Eugenia Vega-Villegas, Marta F. Lopez-Brea, Raul Marquez

  9-19

  Published: 2008-01-01

  • PDF

• Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy

  Ulrich Wedding, Anja Koch, Bernd Röhrig, Ludger Pientka, Heinrich Sauer, Klaus Höffken, Iris Maurer

  56-62

  Published: 2008-01-01

  • PDF

• Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis

  Lucyna Kepka, Krzysztof Bujko, Agnieszka Zolciak-Siwinska

  95-103

  Published: 2008-01-01

  • PDF

• Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC

  Qiuwei Pan, Bisheng Liu, Jin Liu, Rong Cai, Xinyuan Liu, Cheng Qian

  135-144

  Published: 2008-01-01

  • PDF

• Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer

  Marcus Hentrich, Xaver Schiel, Birgit Scheidt, Michael Reitmeier, Ulrike Hoffmann, Ludwig Lutz

  155-156

  Published: 2008-01-01

  • PDF

• Novel therapeutic strategies for neuroendocrine tumours – can eminence replace evidence?

  Jan Zedenius

  3-4

  Published: 2008-01-01

  • PDF

• Will haptic feedback speed up medical imaging? An application to radiation treatment planning

  Eva Anderlind, Marilyn E. Noz, Eva-lotta Sallnäs, Bengt K. Lind, Gerald Q. Maguire jr

  32-37

  Published: 2008-01-01

  • PDF

• Radiotherapy in oncological emergencies – final results of a patterns of care study in Germany, Austria and Switzerland

  Elmar Christian, Irinaeus A. Adamietz, Normann Willich, Ulrich Schäfer, Oliver Micke

  81-89

  Published: 2008-01-01

  • PDF

• Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer

  Eero J. Kumpulainen, Pasi P. Hirvikoski, Risto T. Johansson

  120-123

  Published: 2008-01-01

  • PDF

• A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer

  Daniel Morgensztern, Michael C. Perry, Ramaswamy Govindan

  152-153

  Published: 2008-01-01

  • PDF

• Preoperative staging of rectal cancer

  Neil Smith, Gina Brown

  20-31

  Published: 2008-01-01

  • PDF

• Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer

  Sanne B. Schagen, Willem Boogerd, Martin J. Muller, Wim Ten Bokkel Huinink, Luc Moonen, Wim Meinhardt, Frits S.A.M. Van Dam

  63-70

  Published: 2008-01-01

  • PDF

• Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients

  David Loven, Einat Be'Ery, Rinat Yerushalmi, Claude Koren, Aaron Sulkes, Idit Lavi, Yuval Shaked, Eyal Fenig

  104-109

  Published: 2008-01-01

  • PDF

• Consequences of inadvertent radioiodine treatment of Graves’ disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?

  Gertrud Berg, Lars Jacobsson, Ernst Nyström, Katarina Sjögreen Gleisner, Jan Tennvall

  145-149

  Published: 2008-01-01

  • PDF

• Book Review

  K O’ Byrne, V Rusch

  157

  Published: 2008-01-01

  • PDF

• The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers

  Lennart Blomqvist, Bengt Glimelius

  5-8

  Published: 2008-01-01

  • PDF

• Research in Danish cancer rehabilitation: Social characteristics and late effects of cancer among participants in the FOCARE research project

  Mette terp Høybye, Susanne oksbjerg Dalton, Jane Christensen, Lone ross Larsen, Katrin gaardbo Kuhn, Jette nygaard Jensen, Kathrine Carlsen, Christoffer Johansen

  47-55

  Published: 2008-01-01

  • PDF

• Lack of influence of intravenous contrast on head and neck IMRT dose distributions

  Daniel Létourneau, Marisa Finlay, Brian O' Sullivan, John N. Waldron, Bernard J. Cummings, Jolie Ringash, John J. Kim, Andrew J. Bayley, Laura A. Dawson

  90-94

  Published: 2008-01-01

  • PDF

• Selective in vitro cytotoxic effect of human cancer cells by Bluetongue virus-10

  Jun Hu, Chang-Yuan Dong, Joseph K.-K. Li, Dong-E Chen, Ke Liang, Jun Liu

  124-134

  Published: 2008-01-01

  • PDF

• Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours

  Anouk N. A. Van Der Horst-Schrivers, Madeleine H. E. Bruins Slot, Pax H. B. Willemse, Ido P. Kema, Elisabeth G. E. De Vries, A. N. Machteld Wymenga

  153-155

  Published: 2008-01-01

  • PDF

• Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer

  Anna Sutela, Ritva Vanninen, Mazen Sudah, Marja Berg, Vesa Kiviniemi, Jaana Rummukainen, Vesa Kataja, Vesa Kärjä

  38-46

  Published: 2008-01-01

  • PDF

• Eating ability predicts subsequent quality of life in Chinese patients with breast, liver, lung, or nasopharyngeal carcinoma: A longitudinal analysis

  Wing S. Wong, Richard Fielding

  71-80

  Published: 2008-01-01

  • PDF

• Gemcitabine and cisplatin in locally advanced and metastatic bladder cancer; 3- or 4-week schedule?

  Anne Birgitte Als, Lisa Sengelov, Hans Von Der Maase

  110-119

  Published: 2008-01-01

  • PDF

• The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists

  Nina H. Bjarnason, Michael Christiansen, Lena Specht

  150-151

  Published: 2008-01-01

  • PDF